In this context it is worth noting that therapeutic dosage of aspirin downregulates ribosome biogenesis thus increasing the p53-mediated tumor-suppressor activity, being in this way able to reduce the risk of cancer onset, either or not linked to chronic inflammatory processes [102]. This evidence concerns the gene TP53 and neoplasm.